Loading...

Cann Global Limited

CGB.AXASX
HealthcareDrug Manufacturers - Specialty & Generic
A$0.02
A$0.00(0.00%)

Cann Global Limited (CGB.AX) Stock Overview

Explore Cann Global Limited’s financial performance, market position, analyst ratings, and future outlook.

Stats data is not available for CGB.AXStats details for CGB.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for CGB.AXAnalyst Recommendations details for CGB.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Cann Global Limited engages in the production and distribution of medicinal cannabis medications, natural foods, and cosmeceuticals in Australia and internationally. It operates through Hemp and Medical Cannabis Products, and Mining Exploration and Evaluation segments. The company grows and cultivates hemp and medical cannabis products; provides nutritious and vitamin packed plant-based foods under the Grass Roots brand; and offers skincare products under the Fuss Pot brand. It also engages in the exploration and development of bauxite. The company was formerly known as Queensland Bauxite Limited. Cann Global Limited was incorporated in 2007 and is based in Sydney, Australia.

CEO

Mr. Sholom Dovber Feldman

Headquarters

133 Castlereagh Street, Sydney, NSW

Founded

2008

Frequently Asked Questions